Literature DB >> 15668728

Correlating gene expression with chemical scaffolds of cytotoxic agents: ellipticines as substrates and inhibitors of MDR1.

Y Huang1, P E Blower, C Yang, C Barbacioru, Z Dai, Y Zhang, J J Xiao, K K Chan, W Sadée.   

Abstract

To facilitate a systematic study of chemoresistance across diverse classes of anticancer drug candidates, we performed correlation analyses between cytotoxic drug potency and gene expression in 60 tumor cell lines (NCI-60; NCI-National Cancer Institute). Ellipticine analogs displayed a range of correlation coefficients (r) with MDR1 (ABCB1, encoding multidrug resistance (MDR) protein MDR1 or P-glycoprotein). To determine MDR1 interactions of five ellipticines with diverse MDR1-r values, we employed MDR1-transport and cytotoxicity assays, using MDR1 inhibitors and siRNA-mediated MDR1 downregulation, in MDR1-overexpressing cells. Ellipticines with negative correlations-indicative of MDR1-mediated resistance-were shown to be MDR1 substrates, whereas those with neutral or positive correlations served as MDR1 inhibitors, which escape MDR1-mediated chemoresistance. Correlation with additional genes in the NCI-60 confirmed topoisomerases as ellipticine targets, but suggested distinct mechanisms of action and chemoresistance among them, providing a guide for selecting optimal drug candidates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15668728     DOI: 10.1038/sj.tpj.6500297

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  7 in total

1.  Identification of compounds selectively killing multidrug-resistant cancer cells.

Authors:  Dóra Türk; Matthew D Hall; Benjamin F Chu; Joseph A Ludwig; Henry M Fales; Michael M Gottesman; Gergely Szakács
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

2.  Prediction of anticancer drug potency from expression of genes involved in growth factor signaling.

Authors:  Zunyan Dai; Catalin Barbacioru; Ying Huang; Wolfgang Sadée
Journal:  Pharm Res       Date:  2006-01-26       Impact factor: 4.200

3.  Chemogenomic analysis identifies geldanamycins as substrates and inhibitors of ABCB1.

Authors:  Ying Huang; Paul E Blower; Ruqing Liu; Zunyan Dai; Anh-Nhan Pham; Hojin Moon; Jialong Fang; Wolfgang Sadée
Journal:  Pharm Res       Date:  2007-04-25       Impact factor: 4.200

4.  Pharmacogenomics approach reveals MRP1 (ABCC1)-mediated resistance to geldanamycins.

Authors:  Anh-Nhan Pham; Jeffrey Wang; Jialong Fang; Xin Gao; Yilong Zhang; Paul E Blower; Wolfgang Sadée; Ying Huang
Journal:  Pharm Res       Date:  2008-12-10       Impact factor: 4.200

5.  Impact of terminal dimethylation on the resistance profile of α-N-heterocyclic thiosemicarbazones.

Authors:  Petra Heffeter; Christine Pirker; Christian R Kowol; Gerrit Herrman; Rita Dornetshuber; Walter Miklos; Ute Jungwirth; Gunda Koellensperger; Bernhard K Keppler; Walter Berger
Journal:  Biochem Pharmacol       Date:  2012-03-15       Impact factor: 5.858

6.  Overcoming chemoresistance in prostate cancer with Chinese medicine Tripterygium wilfordii via multiple mechanisms.

Authors:  Zhijun Wang; Ranadheer Ravula; Leming Shi; Yunjie Song; Steven Yeung; Mandy Liu; Bernard Lau; Jijun Hao; Jeffrey Wang; Christopher Wai Kei Lam; Moses Sing Sum Chow; Ying Huang
Journal:  Oncotarget       Date:  2016-09-20

7.  An integrative analysis of small molecule transcriptional responses in the human malaria parasite Plasmodium falciparum.

Authors:  Geoffrey H Siwo; Roger S Smith; Asako Tan; Katrina A Button-Simons; Lisa A Checkley; Michael T Ferdig
Journal:  BMC Genomics       Date:  2015-12-04       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.